Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrition ; 103-104: 111787, 2022.
Article in English | MEDLINE | ID: mdl-36055123

ABSTRACT

The roles of gut microorganisms in cancer are diverse. Studies on metagenomics and bioinformatics have documented diverse microbial etiology in different tumors. Evidence supports that a commensal microbiome could provide a promising strategy to treat and prevent cancer through interference in several biologic processes, such as host cell survival and death, host immune function, inflammation, oncogenic signaling, and several hormone receptor signaling and detoxification pathways. The cumulative evidence recommends that metabolites of commensal gut microorganisms (e.g., short-chain fatty acids, omega-3 and -6 fatty acids) play an important role in cancer prevention, with a robust antiproliferative effect of omega-3 fatty acids. Intriguingly, the endocannabinoid system (omega-3 and -6 fatty acid-derived neurotransmitter of the body) shows diverse effects on cancer prevention and oncogenesis depending on the context of the tumor microenvironment. Thus, an interplay of gut microorganisms with their fatty acid metabolites and the endocannabinoid system play an important role in the development, progression, immunomodulation, and chemoresistance of cancer. In this review, we highlight aspects of the current knowledge of and interactions between the microbiome with fatty acids and the host endocannabinoid system. We also document their effect on host immunomodulation and chemoresistance, and discuss how these insights might translate into future development of microbiome-targeted therapeutic interventions.


Subject(s)
Fatty Acids, Omega-3 , Gastrointestinal Microbiome , Neoplasms , Humans , Endocannabinoids/pharmacology , Fatty Acids/pharmacology , Drug Resistance, Neoplasm , Fatty Acids, Volatile/metabolism , Immunomodulation , Immunity , Fatty Acids, Omega-3/pharmacology , Neoplasms/drug therapy , Tumor Microenvironment
2.
Indian J Med Res ; 143(Supplement): S45-S51, 2016 May.
Article in English | MEDLINE | ID: mdl-27748277

ABSTRACT

BACKGROUND & OBJECTIVES: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size, grade, lymphovascular invasion, oestrogen and progesterone receptor expression and HER2/neu status in patients with breast cancer. METHODS: In this study 426 (with complete information on study variables) patients with breast cancer on treatment during March 2010 to December 2013, were analyzed. TNM (tumour node matastasis) staging was evaluated. The histological grading of tumours was done according to modified Bloom-Richardson Grading System. The immunophenotype of the tumour was determined as the expression of oestrogen (ER) and progesterone (PR) receptors and Her0 2/neu status. Univariate and multivariate analyses were carried out to determine the independent predictors of metastatic lymph node. RESULTS: Among the studied patients, 44.36 per cent (189 of 426) of the patients had nodal metastases. t0 umour histology, tumour grade, size and lympho-vascular invasion were related with node positivity. On univariate analysis, age, menopause, hormone receptor status did not relate with the node metastasis. Age, tumour grade, tumour size, lympho-vascular invasion and HER2/neu expression was likely to be associated with the number of lymph node metastasis. INTERPRETATION & CONCLUSIONS: The lymph node status was associated with clinical stage, tumour grade, tumour histology and HER2/neu status. t0 hese factors may be used for better management of such patients.


Subject(s)
Breast Neoplasms/genetics , Lymph Nodes/pathology , Prognosis , Receptor, ErbB-2/genetics , Adult , Aged , Axilla/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Estrogen Receptor alpha/genetics , Female , Humans , India/epidemiology , Lymph Nodes/metabolism , Lymphatic Metastasis/diagnosis , Lymphatic Metastasis/pathology , Middle Aged , Neoplasm Invasiveness/genetics , Neoplasm Staging , Receptors, Progesterone/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...